Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia

Authors: Pryka R.; Kowalsky S.; Haverstock D.

Source: Clinical Therapeutics, Volume 20, Number 1, January 1998 , pp. 141-155(15)

Publisher: Elsevier

Keywords: ciprofloxacin 750 mg; lower respiratory tract infection; pneumonia; acute exacerbations of chronic bronchitis

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0149-2918(98)80041-6

Affiliations: 1: Bayer Corporation, Pharmaceutical Division, West Haven, Connecticut, U.S.A.

Publication date: 1998-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Pryka R. ;  Kowalsky S. ;  Haverstock D.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers